Reliable identification of expressed somatic insertion/deletion (indels) is an unmet demand due to artifacts generated in PCR-based RNA-Seq library preparation and the lack of normal RNA-Seq data, presenting analytical challenges for discovery of somatic indels in tumor trasncriptome.
10 bases of a splice site (splice region) are considered coding indels and subjected to further analysis.
For each coding indel, RNAlndel extracts reads covering the indel locus to retrieve the actual alignment pileup. This process also enables the incorporation of additional variations such as polymorphisms near the indel into the feature calculation. Matches to the dbSNP database (Build 151) (Sherry et al., 2001) are also annotated as a feature; equivalent indels are also considered during matching ( Supplementary Fig. S1 ). For indels supported by ≥ 2 unique reads, prediction is made by classifiers specifically trained based on their size (i.e., 1-nt or >1-nt), which consist of an ensemble of random forest (Breiman, 2001) models. RNAIndel generates a VCF file where indel entries are parsimonious and left-aligned (Tan et al., 2015) to unify equivalent alignments of supporting reads ( Supplementary Fig. S1 ). Predicted class and probability are reported in the VCF INFO field as well as dbSNP membership, ClinVar (Landrum et al., 2014) annotation, variant effect annotation and calculated feature values. tumor RNA-Seq BAM file is a required input. If an optional VCF file from user's variant caller is supplied, indel calls in the file are used for prediction. Otherwise, indel calling is performed on the input BAM file using the built-in Bambino caller. Features are calculated using alignment pileup, transcript structure, and dbSNP database. Alignments are spliced (dashed) and may contain nonreference variations which alter sequences flanking indels (C>A in green). Indels are annotated for coding exon (grey box) and splice region (light-grey box), defined as an intronic region within 10 nt of the exon boundary. After annotating the dbSNP membership, single nucleotide indels (1-nt) and multi-nucleotide indels (>1-nt) are predicted separately by random forest classifiers specifically trained for each type. Predicted class is based on the highest probability of being somatic, germine or artifact. RNAIndel outputs an annotated VCF file. C. Training set generated from 330 cases. Indel calls in RNA-Seq were classified somatic, germline and artifact by matching with T/N-paired WES and WGS (DNA-Seq) data. B. The 1-nt and >1-nt indel distribution in the categories of somatic, germline and artifacts. The class distribution of each dataset is shown in logarithm scale.
Indel Classifiers

Training set
Each case in the training set (N=330) was sequenced by tumor RNA-Seq, and tumor (T) / normal (N)paired whole exome sequencing (WES) and PCR-free whole genome sequencing (WGS) (Materials and Methods). Coding indel in the training RNA-Seq dataset was labelled somatic, germline or artifact based on the paired WES and WGS analysis ( Fig. 1B) . Specifically, an indel in RNA-Seq was labelled somatic if it matched to a somatic indel identified by the T/N-paired DNA-Seq analysis.
Expressed germline indels were defined if they were supported by the normal WGS and WES. The remaining indels, present in RNA-Seq but absent in WGS and WES, were labelled as artifacts. The resulting training set, comprised of single-nucleotide indel (1-nt) and multi-nucleotide indels (>1-nt), showed distinct distributions in the three categories of somatic, germline, and artifact (Fig. 1C) where 1-nt indels were highly enriched in artifacts. Specifically, 1-nt indels accounted for 115, 12,529, and 616,121 of somatic, germline and artifacts, respectively while >1-nt indels accounted for 213, 45,098, and 91,399 of somatic, germline and artifacts, respectively. An accompanying T/N-paired DNA-Seq analysis identified 959 somatic coding indels in this cohort, showing that 35.2% of them were expressed. Each sample harbored, on average, 0.88 ± 1.19 s.d. expressed somatic indel, ranging from 0 to 6. Top 10 frequent genes involved were ETV6 (11 samples), CCND3 (6) , GATA1 (6), NOTCH1 (6) , PTCH1 (6) , BCOR (5), SETD2 (5), XBP1 (5), PTEN (4) and WT1 (4), highlighting the tumorbiological significance of expressed somatic indels.
Features
We extracted a total of 31 features from sequence/alignment, transcript/protein and database categories (Table 1 and Supplementary Methods). Several features were selected based on the strandslippage hypothesis, a widely accepted model for explaining the mechanism by which indels are generated in the process of DNA replication (Garcia-Diaz and Kunkel, 2006) . Under this model, the DNA polymerase pauses synthesis in repetitive regions, and this delay in replication allows unpaired nucleotides to transiently anneal, leading to a misaligned replication. Thus, features governing sequence complexity (feature 1 3) and annealing temperature (feature 4 7) are expected to be important parameters of this model. By contrast, insertions or deletions that are dissimilar to the flanking sequences are unlikely to be caused by strand slippage (feature 8). Cancer-associated indels may be complex ( Supplementary Fig. S2 ) (Ye et al., 2016) , so we define indel complexity based on misalignments near the indel site. Indel size (feature 10) is negatively correlated to prevalence, and insertions (feature 11) are rarer than deletions in the human genome (Zhang and Gerstein, 2003) .
Polymers of adenine or thymine are known to be more erroneous than guanine or cytosine polymers (feature 12 15) (Fang et al., 2014) . Indels with sufficient read support are more likely to be true (feature 16 18). Mapping artifacts stem from ambiguous mapping (feature 19) or difficulty in mapping spliced reads (feature 20). Equivalent indels are alternative alignments of the identical indel sequence, a type of mapping artifact (feature 21). PCR-based genotyping can frequently create false multiallelic indels (feature 22) (Weber et al., 2002) .
Indels were also characterized in terms of variant effect. In-frame indels are non-truncating unless they create a de novo stop codon. Indels in splicing regions may not affect splicing unless they destroy the splice motif (feature 23 25). Further, in-frame indels may be less deleterious if they occur outside of conserved domains (feature 26). The relative location of indels (feature 27) within proteins is_inframe  24  is_splice  25  is_truncating  26  is_in_cdd  27  indel_location  28  is_nmd_insensitive  29  indels_per_gene  30  coding_seq_length  31 DB is_on_dbsnp are bimodal around the N and C-termini. It has been postulated that transcripts with N-terminual indels can be rescued by an alternative downstream start codon, while a subset of C-terminus truncations may retain the all functional domains (Ng et al., 2008) . Indels in the first and last exons are therefore known to be less sensitive to nonsense mediated decay (NMD) (feature 28) (Popp and Maquat, 2016) . We also hypothesized that the number of true indels in a gene is expected to be few.
The number of detected indels in a gene were normalized by dividing by the coding sequence length (feature 29 30). Finally, indels present in dbSNP are considered more likely to be germline (feature 31).
Optimization
Somatic indel discovery is the most likely application for RNAIndel, a context in which sensitivity is especially critical. For this reason, models were optimized favoring true positive rate (TPR), or sensitivity, of somatic indels over false discovery rate (FDR). As the training set was particularly imbalanced towards artifacts (Fig. 1C ), we downsampled the training set to somatic: germline: artifact = 1: 1: ‫ݔ‬ . The ratio for arifact was determined to maximize F 10 for somatic class on a 5-fold crossvalidataion (Materials and Methods). The downsampled training sets were at somatic: germline: artifact = 1: 1: 18 for 1-nt with a F 10 of 0.7 and 1: 1: 6 for >1-nt with a F 10 of 0.79 ( Supplementary   Table S1 ). The models were further refined for somatic prediction. An optimal subset of the 27 features for each indel class was selected by a greedy best-first search for somatic TPR improvement (Materials and Methods), leading to a set of 11 features for 1-nt and 14 features for >1-nt indel type, respectively (Table 1) . Performance metrics for each class are summarized (Table 2) . Although optimized for somatic prediction, the final models accurately predicted germline and artifact indels as well.
The selected features provided distinct profiles of somatic, germline and artifact indels.
Somatic indels were longer and dissimilar to the flanking sequences. Complex indels were rare but highly specific to the somatic class (Fig. 2) . Somatic indels appeared at any variant allele frequency (VAF) below 0.5 ( Supplementary Fig. S3A ). Germline indels were predominantly non-truncating or enriched for NMD-insensitivity if truncating, and were mostly found in the dbSNP Build 151 database ( Supplementary Fig. S3B ). Artifacts were found in repetitive sequence with slightly lower nucleotide strength, a strong predictor of annealing temperature (Khandelwal and Bhyravabhotla, 2010) , and were predominantly in the lowest VAF range ( Supplementary Fig. S3A and S3C) . Features 'indel size' and 'dissimilarity' for >1-nt indel and 'indel complexity' for both 1-nt and >1-nt indels were selected in the final model. Somatic indels appeared longer and their lengths were frequently not divisible by three as opposed to germline indels. The inserted or deleted sequences in somatic indels were more dissimilar to the flanking sequences. Complex indels ( Supplementary Fig. S2 ) were almost exclusively found in the somatic class.
Performance
Somatic indel discovery from tumor RNA-Seq data
The training set was generated on an Illumina HiSeq 4000 using total RNA library with 125-nt read length. To test if the model was over-fitted to this particular specification, the trained model was evaluated using two unrelated datasets (TestSet1 and TestSet2) with varying library and sequencing specifications (Materials and Methods). Despite the technical differences between these datasets, RNAIndel was able to predict somatic indels at 87 93% TPR, performance comparable to the TPR Table 3 . Somatic prediction in test datasets with different conditions. obtained by the 5-fold CV of the training set (Table 2 ). Stringency was also reasonable: 3 6 indels were predicted to be somatic for 1-nt or >1-nt indel per sample (Table 3 and Supplementary Tables   S2 S5) . Prediction of low-frequency indels (VAF<0.15) was also sensitive with a TPR of 81%
(21/26) in TestSet1 and 92% (12/13) in TestSet2. Notably, in TestSet2, five previously unknown indels with low VAF in known cancer genes were predicted as somatic by RNAIndel, and ultimately validated by manual review of targeted capture exome sequencing ( Supplementary Table S6 ): EP300
Y207fs (VAF: 0.1), CEBPA P23fs (0.17), RAD21 D543fs (0.02), KIT Y418_D419>Y (0.15), and CREBBP S1767fs (0.01).
In addition to de novo indel analysis, RNAIndel also supports custom filtering by an optional user-defined indel panel, which is used to refine somatic prediction. Putative somatic indels matching this panel are assigned to germline or artifact, whichever has the higher probability (Fig. 3 ). This reclassification rule obviates the need to label non-somatic indels as germline or artifact, which can be difficult in the absence of the DNA evidence. Such a non-somatic indel panel would ideally be compiled from normal RNA-Seq data, which may not be available; however, we found that germline and artifact indels misclassified as somatic frequently recur, which offers a practical strategy for compiling an exclusion panel if users have a dataset with DNA-and RNA-Seq performed. For example, we compiled an exclusion panel by collecting non-somatic indels in the training set that were misclassified as somatic in ≥ 3 samples in the 5-fold CV of the final model. After applying the exclusion panel to the predictions in the two independent test sets, the median number of putative indels were 3 (1-nt) and 2 (>1-nt) for TestSet1 and 1 (1-nt and >1-nt) for TestSet2. Users can also prioritize the RNAIndel prediction for pathogenicity by uploading the output VCF file to the St Jude Cloud tool PeCan PIE (https://platform.stjude.cloud/tools/pecan_pie), where the MedalCeremony algorithm (Zhang et al., 2015) ranks variant pathogenicity into four tiers: gold, silver, bronze, and no medal. In the example workflow (Fig. 3) , the two subclonal KIT indels as somatic mutation were rated 'gold', the highest pathogenicity rank, while the other indels did not receive a medal. Details of RNAIndel's performance on pathogenic indel prediction are presented below.
Working with an external variant caller-A GATK example
In addition to calling indels from a BAM file, RNAIndel can accept a VCF file made by an external variant caller (Fig. 1A) . We chose GATK-HC to illustrate this feature for two reasons. First, GATK Best Practice of RNA-Seq variant calling has been documented in detail for GATK-HC with STAR (Materials and Methods). Second, the STAR/GATK-HC pipeline performed the best in a recent comparison study where combinations of a RNA-Seq mapper and a variant caller were tested for detecting known somatic EGFR indels in lung cancer (Sun et al., 2017) . Following this procedure, we evaluated the performance of three approaches for detecting expressed pathogenic indels: RNAIndel with the built-in caller, RNAIndel with GATK-HC, and the Best Practice-based approach without RNAIndel (Fig. 4A ). We used TestSet1 which contained 23 pathogenic indels classified by our MedalCeremony algorithm ( Supplementary Table S7 ) and the RNA-Seq data were analyzed by the three approaches followed by the MedalCeremony classification. RNAIndel with the built-in caller achieved the highest sensitivity (22/23) with one misclassifed as artifact ( Supplementary Table S7 ).
The prediction from the combination of RNAIndel and GATK-HC had the fewest false positives (a total of 7 artifacts were predicted), but this was achieved at a cost of sensitivity: only 14 of the 23 pathogenic indels were predicted as somatic (the remaining 9 indels were not detected by GATK-HC (Supplementary Table S7 )). However, for true indels predicted as somatic by this approach, the predictions coincided with those made by RNAIndel with the built-in caller (14 somatic and 3 germline), suggesting that the prediction was robust between the callers. The Best Practice prediction, i.e., the STAR/GATK-HC pipeline, was the noisiest with 442 artifacts, a rate 10 times higher than the first two approaches and also the lowest in sensitivity: only 13 of the 23 indels were correctly predicted with 1 filtered and 9 undetected (Fig. 4B, and Supplementary Table S7 ). While the RNAIndel-based approaches predicted 3 germline indels as somatic, two were curated as cancer predisposition mutations on ClinVar ( Supplementary Table S8 ): RAD50 K994_E995fs (rs587780154) and BRCA2 P1062_Q1063fs (rs80359374). Of 23 known pathogenic somatic indels in this dataset, 13 indels were detected and predicted as somatic by all approaches (light blue). The ETV6 I48fs frameshift was detected and predicted as somatic by RNAIndel and RNAIndel with GATK-HC, but filtered by the Best Practice Filtration step (green). Eight indels with lower VAF values were detected and predicted as somatic by RNAIndel (pink), but not detected by the other approaches. The ARID1A K1072fs frameshift was detected but predicted as artifact by RNAIndel, and not detected by the other approaches (gray).
Because GATK-HC locally assembles haplotypes while detecting variants, it may not report indels as aligned in the BAM file, and so these may not be recovered by RNAIndel's indel search (Methods). In TestSet1, nearly half the unrecovered indels (48.6%) were located in reads spanning intron-exon boundaries. Unrecovered exonic indels were most frequently located in human leukocyte antigen (HLA) loci (12.5%). For further investigation, 100 unrecovered indels were randomly selected and reviewed: 47 cases were in intron-exon boundaries, 14 at HLA loci and 39 non-HLA exon cases ( Supplementary Table S9 ). Remapping to the genome by the BLAT algorithm (Kent, 2002) confirmed that 44 of the 47 intron cases were mis-alignments over splice junctions. The remaining 3 cases were ambiguous, with low quality mappings. The high degree of genetic diversity at HLA loci likely explains the unsuccessful recovery. The 39 non-HLA exonic indels were also re-mapped by BLAT, revealing 17 mis-mappings. Of the remaining 22 exonic indels, 15 were found in repeats where somatic indels are less frequent as characterized in this study, 4 were in non-repetitive regions and 3 cases should have been realigned as a SNV or a cluster of SNVs rather than an indel. Considering that a majority of these indels were mismappings or in HLA loci, the impact of the underreporting may be marginal to the somatic prediction; indeed, all of the 23 somatic indels were successfully recovered in TestSet1.
Discussion
We developed RNAIndel, a machine-learning based method to classify coding indel calls in RNA-Seq data. The performance of a machine learning method is constrained by the quality of the training set.
In our initial assessment, nearly one third of RNA-Seq indels supported by WES were not validated by further investigations, suggesting that they were PCR artifacts common to both platforms. To construct a high-quality training set, we employed three-platform clinical sequencing of WGS, WES and RNA-Seq with WGS data generated from a PCR-free library protocol (Rusch et al., 2018) .
Previously, we have shown that this approach achieved a positive predictive rate of 98.8% and a sensitivity of 94.3% for exonic indels, assuring the quality of the training set (Rusch et al., 2018) . A possible limitation of the training set is that indels in the set were predominantly small indels with the maximum length being 23-nt. Analysis of larger indels may require tools designed for structural variation detection. This method was optimized and evaluated for somatic indel prediction using two unrelated test datasets generated under varying conditions. RNAIndel robustly predicted somatic indels with a TPR of ~0.9. The ability to predict low-frequency variants is particularly important as tumor heterogeneity is the source of tumor clonal evolution causing resistance to cancer treatment.
However, false negatives are frequent in these low VAF variants because artifacts are predominantly distributed in this VAF range ( Supplementary Fig. S3A ). RNAIndel is able to discern subclonal indels with VAF <0.15 from artifacts at a TPR >0.8. This sensitivity enabled the discovery of novel somatic indels in TestSet2 which had not been identified by 500× targeted sequencing, possibly due to subclonality.
Features assigned to variants by the software are used to inform its classification logic and at times may unveil interesting biological insights. For example, the strand-slippage model predicts a simple indel with the flanking sequence. Two of our assigned features capture this state; the feature 'dissimilarity' is set to zero if the indel matches its flanking sequence, and the feature 'indel_complexity' is set to zero for simple indels. Interestingly, somatic indels frequently deviated from the slippage model, while germline and artifact indels were generally consistent with it (Fig. 2) .
This may be because the mechanism of somatic indel acquisition differs from that of germline due to the instability of cancer genome. Alternatively, one may speculate that a high proportion of indels compatible with the slippage model tend to be under weaker selection pressure and may hence appear in germline. For example, a triplet indel in a tandem tri-nucleotide repeat region is a pattern typical of germline indels and can be explained by strand slippage. This type of indel may have limited impact on protein function due to the possible redundancy of the repetitive amino acid molecules.
Like other variant discovery tools, RNAIndel does expect users to review the predicted outputs. In our review, single nucleotide indels (1-nt) with 'alt_count' being 2 or 3 appeared as a major source of misclassification. As a strategy to review such indels, we recommend applying a panel of non-somatic indels (Fig. 3) , gene prioritization (Fig. 3) , using another indel caller (Fig. 4) to confirm consensus, visual inspection of the indel alignments, and reasoning by user's domain knowledge of the disease being investigated. Despite this limitation, RNAIndel enables an unbiased screening of somatic indels from tumor RNA-Seq data alone; an application of RNA-Seq data which has not been attempted due to the lack of suitable tools.
Materials and Methods
Datasets
All RNA-Seq data sets in this study, which consisted of a training set and two test sets, were mapped by STAR in 2-pass mode to GRCh38 (Supplementary Methods).
The training set was a dataset comprised of paired tumor (T) / normal (N) whole WGS and WES, and tumor RNA-Seq generated from 330 pediatric cancer patients from 17 major cancer types ( Supplementary Table S10 ). Importantly, the WGS libraries were prepared by a PCR-free protocol to minimize PCR-artifacts. The details of nucleic acid extraction, library preparation, sequencing and variant detection were previously described (Rusch et al., 2018) .
Two public datasets were used as test sets. The first set (TestSet1) was comprised of 77 RNA-Seq samples of 20 tumor types ( Supplementary Table S2 ) previously used for developing a clinical pipeline (Rusch et al., 2018) 
